Scholars Central

Conference abstractPublished 19 Apr 2018

Genome instability in pulmonary tuberculosis

Authors: Tamar J Buadze, Tinatin A Jokhadze, Maya N Gaiozishvili, Nana A Kiria, Teimuraz A Lezhava

Ivane Javakhishvili Tbilisi State University, Georgia National Centre of Tuberculosis and Lung Diseases, Georgia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pulmonary tuberculosis (PT) is classified as a disease with a hereditary predisposition. Genetic factors contribute to the outcome of primary PT infection with an estimated heritability of more than 50%. The genotype of an organism plays an important role in the development of PT diseases. Numerous studies have been performed to identify genetic factors responsible for variation in PT susceptibility. However, none of the candidate genes was associated with susceptibility to active PT. Therefore, as with all the pathologies related to this group, particular importance is attached to finding those markers that enable early detection of high risk groups of the disease in the population. Data on the variability of such informative and important functional parameters, which are associated with the epigenetic processes in PT are practically absent. The aim of our study was to evaluate genetic and epigenetic variation of the genome in patients with sensitive pulmonary tuberculosis before and after treatment, under the effect of peptide bioregulator-Ala-Glu-Asp-Gly. In lymphocyte cultures from patients with sensitive primary PT were studied facultative heterochromatin (sister chromatid exchanges - SCE) and mutation (chromosome aberrations). We determined that there was an epigenetic alteration of functional parameters of the genome in PT before treatment. The level of heterochromatin decreased in the telomeric regions of chromosomes - A1, A2, B, C, D, F and G (in control it was high) and increased in the middle regions of chromosomes - A1, B, C, E, F and G (in control it was reduced). There was a high level of somatic recombination, revealed an increase of the frequency of cells with chromosome aberrations. The bioregulator (Ala-Glu-Asp-Gly) could be used as an aid in the prevention and treatment of tuberculosis. Redistribution of heterochromatin from the telomeric to middle chromosome arms and increasing of chromosome aberrations make it possible to define a sensitive form of PT and then monitor the results of treatment

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Molecular and Genetic Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalMolecular and Genetic Medicine
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Tamar J Buadze”
  • BylineArticles whose byline prints “Tinatin A Jokhadze”
  • BylineArticles whose byline prints “Maya N Gaiozishvili”
  • BylineArticles whose byline prints “Nana A Kiria”
  • BylineArticles whose byline prints “Teimuraz A Lezhava”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels